1. Introduction {#sec1}
===============

1.1. miRNAs {#sec1.1}
-----------

miRNAs are a group of noncoding small RNAs with 21--23 nucleotides in length, which have specific interactions with their special mRNAs. They degrade the mRNA and inhibit the translation. miRNA genes comprise about 1% of the genome of different species, and each of them has hundreds of target genes. Over 2500 miRNAs have been identified in the human genome that regulate 30% of the proteins\' coding genes. These small regulatory molecules were first identified in 1993, are found mainly in the chromosomal fragile sites, and in various diseases, are prone to deletion, addition, chromosomal translocation, and epigenetic changes ([@bib4], [@bib7]).

1.2. miRNA biogenesis {#sec1.2}
---------------------

miRNA in the nucleus transcripts the gene and produces pri-miRNA and subsequently a precursor named pre-miRNA under the nuclear RNaseIII (endonuclease) enzyme called Drosha. Afterwards, pre-miRNA is transported to the cytoplasm by the protein Exportin 5. The molecule is cleaved by another enzyme called Dicer in the cytoplasm and develops a 21- to 23-nucleotide, double-stranded sequence. One of the strands is decomposed and the other strand is localized in the silencer complex (RNA-RISC) ([Fig. 1](#fig1){ref-type="fig"}). This activates the complex targets of the intended mRNA, binds to the mRNA 3′UTR end, and exerts its inhibitory effect. Through inhibiting protein translation or decomposing the target mRNA, miRNA exerts its effects in regulating gene expression ([@bib4], [@bib7], [@bib5]).Fig. 1miRNA biogenesis is a multistep process 1- miRNA genes are transcribed by RNA polymerase II in the nucleus 2- the resulting primary transcript is cleaved by Drosha to produce pre-miRNA 3- exportin-5 mediated transport pre-miRNA to the cytoplasm 4- pre-miRNA undergoes its final processing step, which consists of Dicer-dependent cleavage just below the stem loop to produce a miRNA duplex 5- The mature miRNA strand is subsequently incorporated into the RNA-induced silencing complex (RISC) where it directly binds to a member of the AGO protein family ([@bib7], [@bib33]).Fig. 1

2. miRNA-183 family {#sec2}
===================

The family miRNA-183 consists of three miRs: 183, 96 and 182. These miRNAs are concurrently expressed during development and are required for proper development of the sensory organs ([@bib11]). miR-96 was the first identified human miRNA of the cluster ([@bib39]), and miR-182 and miR-183 were identified one year later ([@bib28], [@bib22], [@bib3]). The three miRNAs are located adjacent to each other, with about 4 kb-span between miR-96 and miR-182, and transcribed as a long primary transcript. Then, they are processed into three individual precursor miRNAs ([@bib17]). The sequence homology of miRs-183, - 96 and -182 and the conservation of their genomic organization as a cluster in bilaterian organisms represent an evolutionary benefit. In humans, the cluster is located on chromosome 7, with a 4.2 kb intergenic region between miRs-96 and -182. However, the murine miR-183 cluster is located on chromosome 6 with 3.6 kb between miRs-96 and -182 ([@bib11]). Mutation in miRNA-96 causes deafness in the locus of DFNA50. However, miRNA-96 is one of the members of miRNA-183 family, and miRNA-183, 182, 96 are all derived from a common primary transcript ([@bib53], [@bib58], [@bib43]). In addition, miRNA-183 family members have a highly similar sequence ([@bib32]) ([Fig. 2](#fig2){ref-type="fig"}). Interestingly, evolutionary variance from U to A in miRNA-183 causes miRNA-183 to have more widely different target genes, which represents a more unique activity of this miR ([Fig. 2](#fig2){ref-type="fig"}) ([@bib43], [@bib42]).Fig. 2The mature miR-183, -96 and -182 have approximately identical seed sequences, and a single base difference in the seed sequence of miR-96 and -182 is essential for its mRNA target specificity.Fig. 2

2.1. Mutations in miR-96 and deafness {#sec2.1}
-------------------------------------

Locus DFNA50 in humans on chromosome 7q32 is a new locus of age-dependent non-syndromic dominant autosomal deafness. This site is located on chromosome 6 in mice ([@bib24], [@bib38]). According to reports, three single point mutations in the regions of miR-96 gene were identified in humans and mice ([@bib24], [@bib48]). These studies for the first time showed that miRNA mutation caused a genetic disorder. Study of cell culture showed an 80% reduction in the processing of mutant miR-96 and disorder in identifying target genes, i. e. reducing the target genes and gaining new target genes ([@bib36]).

However, mutation of miR-96 in Diminuendo mice does not affect miRNA processing greatly, but this mutation causes disorder in the target detection. In addition, disorder in the genes, that were not the direct target of mutant miR-96 or miR-96, were detected; however, they are important for the maintenance and function of the inner ear ([@bib24]). Overall, the data suggest that the mutation in miR-96 results in both loss-of-function (LOF) and gain-of-function (GOF). A mutation was identified in pre-miR-96 in humans that causes progressive hereditary deafness. This mutation causes an 85% reduction in the processing of miR-96, while in the processed transcript, miR-96 sequence and mRNA target were correct ([@bib48]); consequently, two families with mutations in miR-96 sequence caused a deeper hearing loss at a young age than the mutations in the pre-miR-96 ([Fig. 3](#fig3){ref-type="fig"}) ([@bib48], [@bib36]).Fig. 3miR-96 precursor. Mutations in locus DFNA50, miR-96 gene seed sequence or precursor hairpin sequence in humans and mice cause deafness.Fig. 3

2.2. Expression patterns of miRNA-183 family {#sec2.2}
--------------------------------------------

Homologues of miRNA-183 family members are present in invertebrates of miR-263a, miR-263b and miR-228 which were separated 600 million years ago ([@bib42], [@bib45]). miRNA 183 family members are highly conserved in neurosensory organs and cells in both deuterostomes and protostomes. The members of miRNA-183 family were identified in the inner ear hair cells and sensory neurons in mice ([@bib53], [@bib24], [@bib49], [@bib13], [@bib54]), and miR-263 family members were detected in Johnston\'s organs of drosophila and haltere ([@bib42]), which highlights the role of this family in the development and maintenance of neurosensory system. Similarly, this family was identified in the neurosensory cells of the mice\'s eyes ([@bib58], [@bib29], [@bib30]) and retina of zebrafish ([@bib56]). miRNA-183 family expression increases with radiation or is affected by light ([@bib20]), and is associated with circadian rhythm in Drosophila ([@bib59]) and mouse ([@bib58]). In addition, this family was identified in the skull and spinal ganglion in mice ([@bib2], [@bib25]), chick ([@bib12]) and zebrafish ([@bib56]). In addition, this family was identified in the neuromasts of zebrafish ([@bib56]) as well as in the neuromasts and electroreceptors of Salamander skin; eventually, the family was detected in the sensory organ of sea urchin ([@bib42]). The expression of the family in neurosensory organs and cells in the majority of families (phyla) shows that this family is vital for the formation and operation of the neurosensory organs.

2.3. Experimental models of miR-183 family activity {#sec2.3}
---------------------------------------------------

Study of experimental models shows different roles of miR-183 family in the development and activities. In the inner ear of Zebrafish, knocking down the family decreases the number of hair cells; therefore, the family is essential for hair cell formation. In addition, increased expression of this family causes production of ectopic hair cells. It has been demonstrated that miR-183 family suffices to induce the formation of hair cells in Zebrafish. In addition, increased expression of miR-182 can compensate the miR-96 knockdown to some extent, which implies overlapping of family activities ([@bib25]). In mice, mutations in miR-96 result in circling behaviors, atria activity disorder, defects in synaptogenesis, growth delay, stereocilia disorder in hair cells, and eventually hair cells death and profound deafness ([@bib24], [@bib21]). Similarly, miR-183 was inactivated in mice with gene-trap technique, and mice showed circling 26 behaviors and imbalance in walking with deep atrial disorder which imply the inner ear\'s defect. Moreover, knocking down miR-96 in Xenopus causes serious eye defect and a defect in the cartilage of the skull ([@bib15]). In addition, removing miR-96 homologue in invertebrates (miR-263 and miR263-b) in drosophila caused reduction in mechanosensory bristles on the head, chest and inner omitidia in the eye. Therefore, miR-263 and miR263-b have an important role in the maintenance and pattern of the neurosensory cells. In mice where Dgcr8 is removed (knocked out) in cone photoreceptors, increased expression of miR-183 and -182 suffices to save and restore normal phenotype, which compensates for the deficiency ([@bib8]). However, no retinal phenotype was found in humans or mice with a mutation in the miR-96 ([@bib24], [@bib48], [@bib36]). This phenotype was not found in mice where miR-182 was knocked out ([@bib18]). Interestingly, a sponge transgenic mouse where miR-183 family members were removed was placed under the control of an opsin promoter which produced a sequence complementary to miR-183 family members. In this kind of mouse, morphological and functional changes in the eye were not observed after six months. In addition, when they were exposed to 10000lux for 30 min, no change occurred, but the morphological and functional changes were observed in the mouse with the knockout of this family; the mice were found to be vulnerable to light. Similarly, a gene-trap model which inserts a retroviral structure into the upstream splicing acceptor of miR-183 that effectively knocks out this miRNA, leads to synaptic, degeneration, and retinal activity defects. When they are exposed to light, the symptoms are aggravated. The physiological defect in the eye can be detected before the tissue defect ([@bib30]). Overall, miR-183 family models in the neurosensory tissues exhibits the importance of the family to protect cells against neural stimuli, with additional roles in development, patterns and synaptogenesis.

The loss of family members results in stereocilia defect in the hair cell, which confirms that each member of the family is required for the hair cell maintenance. In the analysis of transcriptome of hair cells in adults and newborns, hundreds of target genes were predicted for this family; these genes in hair cells are synchronous with miR-183 co-localized family. This family is highly expressed during hair cell development, and has a reverse slope in mature hair cells with functional activity ([@bib54]). It seems that the dose of this family has a key role in hair cell maintenance and function, and therefore normal hair cell survival patterns were associated with increased expression of family-183, which reflects the potential protective impact that may be helpful for hair cell survival. Since these families are expressed in the neurosensory organs and cells, dysfunction of the family can lead to neurosensory impairment in vision, smell, and touch. These findings along with the controlled studies on the knockdown model of this family with sponge-transgenic technique ([@bib61]), and knocking out the family with gene-trap technique ([@bib30]) showed that the removal of the family could lead to vulnerability to neurosensory stimuli. As a result, defect in synaptogenesis was observed in the knocked-out mice of miR-183 family with gene-trap technique ([@bib30]) and the mice with mutant miR-96 ([@bib21]). The defects in synaptogenesis may cause hearing loss in knockout models of the family. Taok1, a target of miRNA-183, inhibition of miR-183 with morpholino antisense oligos in cochlear organotypic cultures revealed a negative correlation between the expression levels of miR-183 and Taok1, suggesting the presence of a miR-183/Taok1 target pair. The miR-183/Taok1 target pair is likely to play a role in degenerative process of the cochlea following acoustic overstimulation ([@bib41]).

3. Discussion {#sec3}
=============

Aging and exposure to noise are two of the most common causes of hearing loss ([@bib24]), and if accompanied by genetic defects, they contribute to sensitivity as well ([@bib55]). Increased life expectancy ([@bib34]) and exposure to environmental noise make a large population at risk of neurosensory hearing damage and dysfunction ([@bib46]). Neurosensory deafness is caused by impairment or loss of mechanosensory hair cells or spiral ganglion neurons (SGNs). In addition, beyond the inner ear, these deficits appear to occur in the central nervous system in the auditory pathway ([@bib50]). For the development of effective therapeutic strategies to treat damaged hair cells, the important step is to identify the regulatory mechanisms involved in hair cell damage ([@bib25]). Recent studies suggest that a common mechanism is involved in the development and reprogramming of cells in the inner ear of a large number of vertebrates. Currently, hearing aids can help the majority of the hearing impaired adult population ([@bib57], [@bib1]). In addition, cochlear implant provides a function by bypassing the hair cell function, which is required for SGNs ([@bib60]). In addition, the auditory brainstem implants in the cochlear nucleus can bypass the function of the inner ear and SGN and provide modest improvements in speech understanding and recognition ([@bib35]). However, none of these hearing aids are able to restore normal and critical hearing range. Although birds and fish can regenerate the hair cells, mammals lack this capacity of regeneration ([@bib6]); however, in a temporary, limited and deficient way, the potential of the hair cells spontaneous generation exists in the cochlea of the neonatal mouse following the hair cells genetic defect ([@bib10]).

3.1. miRNA-183 family and molecular therapies have the potential to regenerate hair cell and auditory nerves {#sec3.1}
------------------------------------------------------------------------------------------------------------

Current strategies of the molecular therapies for deafness include gene therapy, hair cell reproduction, and SGNs. For successful regeneration, the production of the complex anatomy of the hair cells, supporting cell (SC) and SGNs is required to achieve operational results. In addition, the SCs are converted to hair cells through transdifferentiation and inhibition of Notch1 in vivo ([@bib31], [@bib26]). Inhibition of Notch pathway in adult cochlea after auditory trauma leads to a relative improvement, which is attributed to transdifferentiation of the SCs to the hair cells ([@bib37]). In addition, ectopic expression of Ntf3 in the SC following the auditory trauma repairs synapse ([@bib51]). Exogenous Ntf3 shows that it has the potential to increase the survival of SGN ([@bib23]) and can improve the cochlear implant ability. Overall, access to new treatments and facilitation of hair cells repair or regeneration seem promising. In addition, combined gene therapy has achieved certain successes in cell reprogramming ([@bib19], [@bib40], [@bib27]), and gene transfer has been replaced with small molecule therapies ([@bib16], [@bib14]). Meanwhile, the regulatory roles of the miRNAs including miRNA-183, and some genes such as ATOH1, POU4F3, and GFI1 have been confirmed in the differentiation of stem cells from hair cells and protecting hair cells during the studies of ear development stages and stem cell research. These genes have potential to help to restore hearing ([@bib9]). The need for miRNA has been identified in the evolution of ear after blocking miRNAs biosynthesis by genetic engineering strategies during the early stages of ear development and hair cells differentiation. Since hundreds of transcripts are regulated by miRNAs simultaneously, miRNAs can be used as potential therapeutic agents for the repair or regeneration of the hair cells in animal models ([@bib52]). Since a large part of the human transcriptome is regulated by multiple miRNAs, and because of the potential impact of these molecules on gene expression, they can be used for the diagnosis, prognosis and development of drugs. Despite advances in cochlear implants for the treatment of sensorineural hearing loss, hearing improvement is moderate in treated patients. A combination of molecular and stem cells is a viable alternative to cochlear implants which may realize the promise to cure deafness. Transdifferentiation of SC cells into hair cells, which does not happen under natural conditions, may be possible with the help of miRNA, especially miR-183 family in adult mammals.

3.2. Therapeutic potential of miR-183 family {#sec3.2}
--------------------------------------------

Transcriptomic analysis may also help to identify the affected pathways which can serve as new therapeutic mechanisms to protect or restore inner ear neurosensory activity. miRNAs have the potential to be used in the treatment of deafness. As a result, the search for miRNAs as a target to treat deafness can help to offer a promising approach. Molecular therapies are being investigated in clinical trials with anti-miRNA LNA (miravirsen) and mimic miRNA (MRX34), but most of miRNA therapeutics are still in pre-clinical phase ([@bib44]). Identification of miR-183 family target genes and the affected pathways is expected to provide important information about the development and maintenance of the inner ear, and potential pharmaceutical targets to accelerate and develop the protection of the sensory cells.

3.3. Potential of miRNA-183 family as a diagnostic and prognostic biomarker {#sec3.3}
---------------------------------------------------------------------------

Recently, miRNAs have been seriously considered to serve biomarkers in blood circulation due to their frequency and strength in the serum and plasma. Much more research is needed to prove the concurrency between changes in miRNA profiles and high noise in order to use miRNAs as biomarkers to detect sound-induced hearing loss ([@bib36], [@bib47]). In the recent years, serious efforts have been made to introduce an appropriate molecular marker that can predict the diverse nature of deafness and be used as a diagnostic and prognostic tool alongside other pathological-clinical methods. In addition, the miRNAs have certain disorders in deafness and play a vital role in the development and progression of deafness. Given the fact that most common methods for screening cannot detect deafness at early stages, identification of miRNAs that are released into the bloodstream in the onset and progression of deafness is considered a key approach to early detection of deafness. Therefore, in the near future, by measuring the levels of the miRNAs in the serum samples of deaf people, these molecules can be used as molecular markers for the diagnosis and prognosis of different types of deafness such as deafness due to age-related hearing loss (ARHL) and noise-induced hearing loss (NIHL), Inflammation, cholesteatoma, and Schwannomas.

4. Conclusion {#sec4}
=============

miRNAs are a large family of small genes that cause small changes in the expression of the target genes to cause a noticeable impact on the development, specification, maintenance, and survival. The major challenge in the field of miRNAs is to detect the specific biological roles for each miRNA. With regard to the potential of the miRNAs for therapeutic uses, particularly in terms to the possibility of safe and effective targeting of the cells, many questions still remain unansweredin this field, and their roles in abnormal biology and pathology have not yet been completely elucidated. The various effects observed in abnormal biology imply that we should take into account the therapeutic effects of this family more seriously and the target cells to avoid associated side effects. A more in-depth understanding of the miRNA-183 family in both normal and abnormal biological conditions is required for access to activities of miRNA-183 family for the diagnosis and regeneration potential. Regulation of miRNA by miRNAs concentration, the concentration of the target genes, affinity of binding and the effect on gene expression are complex issues. In addition, it is difficult to determine what combination or subset of genes is responsible for producing the phenotype. In knockout models of miRNA -183 family, miRNA dose appears to be essential for the maintenance and cellular activity; increasing the severity of the disease phenotype reduces the expression and dose of this family. Two key concepts were drawn from the expression of miRNA-183 family in normal and abnormal biology of the neurosensory system: 1- expression and level of expression of miRNA-183 family is essential for the survival and vital activity of neurosensory cells, and 2- misexpression can have profound effects on the development and maintenance of neurosensory organs and cells. Thus, further improvements are essential to evaluate the sensitivity and accuracy of the specific biological roles of miRNA-183 family.
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